Scientists find new way to combat drug resistance in skin cancer
5/22/2014
Rapid Resistance to vemurafenib - a treatment for a type of advanced melanoma, the deadliest form of skin cancer - could be prevented by blocking a druggable family of proteins, according to...
Cholesterol plays a key role in cell migration
5/22/2014
University of Barcelona's researchers led by Professor Carles Enrich, from the Department of Cell Biology, Immunology and Neurosciences of the Faculty of Medicine at the University of Barcelona...
Potentially viable drug from pine bark for the treatment of melanoma
5/22/2014
A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers.
How streptococcal bacteria can be used to fight colon cancer
5/22/2014
Researchers at Western University (London, Canada) have shown how the bacteria primarily responsible for causing strep throat can be used to fight colon cancer.
Double mastectomy 'not necessary' for most women, study says
5/22/2014
Research from the University of Michigan finds that 70% of women who had both breasts removed following breast cancer diagnosis could have had a lumpectomy instead.
Early steps of totipotency in sperm precursors uncovered
5/22/2014
In the body, a skin cell will always be skin, and a heart cell will always be heart.
Double mastectomy 'not necessary' for most women who receive one
5/22/2014
Research from the University of Michigan finds that 70% of women who had both breasts removed following breast cancer diagnosis could have had a lumpectomy instead.
Prolaris® test predicts mortality risk in prostate cancer biopsy study
5/21/2014
Myriad Genetics, Inc. has presented new data from a clinical validation study of Prolaris at the 2014 American Urological Association (AUA) Annual Meeting in Orlando, Fla.
Metabolic syndrome disorders, diet may boost prostate cancer risk
5/21/2014
Three new studies featuring the impact of dietary and lifestyle factors on prostate cancer were presented during the 109th Annual Scientific Meeting of the American Urological Association (AUA).
Multiplexed testing of lung cancer tumors identified genetic alterations that were helpful in selecting targeted treatments.